Management of Medicines and Pharmaceutical Supplies for use

  • Slides: 19
Download presentation

Management of Medicines and Pharmaceutical Supplies for use in the prevention and treatment of

Management of Medicines and Pharmaceutical Supplies for use in the prevention and treatment of Preeclampsia and Eclampsia Grace Adeya, SPS/MSH February 23, 2011

Why Consider Medicine and Pharmaceutical Supplies Management Issues? § Effective management of PE/E helps

Why Consider Medicine and Pharmaceutical Supplies Management Issues? § Effective management of PE/E helps ensure that medicines and supplies are on hand for immediate administration. § Effective management requires careful product selection, procurement, storage, distribution, and use. § PE/E medicines are in many countries part of the national pharmaceutical supply system § Subject to the same structural, financial and human resource constraints as all products that rely on this supply system

Pharmaceutical Management Cycle

Pharmaceutical Management Cycle

Selection § § Build consensus on protocol for PE/E with committee of experts and

Selection § § Build consensus on protocol for PE/E with committee of experts and consult best practices Use the following selection criteria § At what level of health system? Who will use them? § Types of medicines? First-line medicine? § Cost § Safety and efficacy § Quality and stability (storage conditions) § Availability for procurement § Registered for use in country? § Include selected PE/E in national essential medicines list (EML) and standard treatment guidelines (STGs)

Selection: Who is making the purchasing decisions at the health facility level? Background of

Selection: Who is making the purchasing decisions at the health facility level? Background of personnel managing medicines at health facility level DRC (N = 30) 7 % pharmacy technicians 80% Nurses Mali (N=100) 18% - pharmacists 3% - pharmacy technicians 4. 8% - matron/nurse/midwife 22% - no training Percentage of respondents trained in the management of uterotonic / PE/E medicines 27% 21% 0% 45% 41% 28% 90% 65% 14% 2% 37. 3% 15% Proportion of Facilities with a copy of the NEML Percentage of respondents who know Mg. SO 4 is in the NEML Percentage of respondents who know Oxytocin is in the NEML Percentage of respondents who know Calcium Gluconate is in the NEML Percentage of respondents who know Diazepam is in the NEML

Procurement § Quantity needed § Cost § Quality: packaging, cold chain § Shelf life

Procurement § Quantity needed § Cost § Quality: packaging, cold chain § Shelf life § Supplier performance § Management information system (MIS) to monitor consumption § Medical Supplies e. g. BP machines

Procurement: Staff knowledge and use of essential data for quantification of requirements Knowledge of

Procurement: Staff knowledge and use of essential data for quantification of requirements Knowledge of the stock on hand DRC (N = 30) Mali (N=100) 70% 58% Knowledge of the quantity dispensed per day 53% 5% Knowledge of the facility’s consumption for one month 47% 4% Knowledge of when and how the medicines were used 33% 7% Ability to use the recorded data for retrospective analysis 10%

The Procurement Cycle

The Procurement Cycle

Selection: Cost and Product versatility issues Year Product Name 2007 2008 2009 Average Diazepam

Selection: Cost and Product versatility issues Year Product Name 2007 2008 2009 Average Diazepam 5 mg/ml (general anticonvulsant/antiepileptic; generalized anxiety; pre-operative) Average of Supplier (US$) $ 0. 06 $ 0. 07 Average of Buyer (US$) $ 0. 08 $ 0. 10 $ 0. 06 $ 0. 08 Magnesium Sulfate 500 mg/ml (PE/E anticonvulsant ) Average of Supplier (US$) $ 0. 09 $ 0. 10 $ 0. 09 Average of Buyer (US$) $ 0. 17 Source: MSH International Drug Price Indicator Guide

Distribution and Inventory Management § Effects of heat and light § Cold chain equipment

Distribution and Inventory Management § Effects of heat and light § Cold chain equipment and transportation § Cold box or packs § Refrigerators § Excursion? § Inventory monitoring system § Stock cards and registers § Distribution network and transportation § Vertical vs. Integrated (How do PE/E products fit into overall supply system? ) § Delivery kit system? § Non-facility locations

Distribution: Storage Conditions DRC (N = 30) Mali (N=60) Stock/storage location is secure (locked

Distribution: Storage Conditions DRC (N = 30) Mali (N=60) Stock/storage location is secure (locked door, wire mesh on the windows, locked cabinets) 83% 87% Storage location is visibly free of harmful insects and rodents 83% Products are arranged well on shelves or pallets 78% 92% Products are arranged so that identification labels and expiration or manufacture dates are visible 67% 82% Products are stored and organized according to expiration dates (FEFO) 67% 85% Boxes and products are in good condition 94% 87% Boxes and products are protected from water and moisture 94% 80% Products are protected from direct light and sun at all times 94% 88% The store has operational refrigerators 28% 43% The temperature of the cold chain is recorded and monitored regularly 0% 7% Temperatures of the cold chain are between 2°C and 8°C 0% 3% Storage Conditions

Use § Policy: Who is allowed to prescribe Mg. SO 4? § Training in

Use § Policy: Who is allowed to prescribe Mg. SO 4? § Training in PE/E management: What skills are needed? § Service delivery protocols § § Indications Dose Contraindications Management of side effects § Skilled birth attendants § Client counseling § Adverse drug reaction monitoring

USE: Respondents Knowledge of Recommended Treatment DRC (N = 30) Mali (N=100) Percentage of

USE: Respondents Knowledge of Recommended Treatment DRC (N = 30) Mali (N=100) Percentage of respondents who know Oxytocin is the recommended medicine for the practice of AMSTL 90% 56% Percentage of respondents who know Mg. SO 4 is the recommended medicine for the management of PE/E 8% 23%

USE: Product Availability DRC (n = 18) Mali (n = 60) - 46% Oxytocin

USE: Product Availability DRC (n = 18) Mali (n = 60) - 46% Oxytocin 10 IU/ml ampoule 78% 34% Magnesium sulfate 4 g ampoule 11% 10% Magnesium sulfate 2 g ampoule - 9% Calcium gluconate 10 mg ampoule 22% 15% Diazepam 10 mg inj 56% - Medicines Available Oxytocin 5 IU/ml ampoule

Management Support § Standard Operating Procedures § Financing § Information management (MIS) § Human

Management Support § Standard Operating Procedures § Financing § Information management (MIS) § Human resources § Preservice education § Continuing education § In-service education § Monitoring and supervision

Management Support: § Advocacy for Maternal Health: § Maternal health issues should always be

Management Support: § Advocacy for Maternal Health: § Maternal health issues should always be included among the health priorities. § Are maternal health program personnel at the table when decisions are being made on priorities for procurement § Forum for improved and regular communication between doctors, midwives and pharmacists e. g Drug and Therapeutics Committees § Improved selection, quantification and ordering of uterotonics § Clarification of roles and responsibilities of pharmacy, delivery room and recovery ward personnel

Policy and Legal Framework § § § § EML and STG Registration issues Importation

Policy and Legal Framework § § § § EML and STG Registration issues Importation Centralized vs. decentralized; vertical vs. integrated programs Financing mechanisms: cost recovery, cost sharing, insurance Pharmacovigilance PE/E service delivery protocols Human resources: who is authorized to prescribe and dispense?

Thank you

Thank you